Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Satoru Sugie is active.

Publication


Featured researches published by Satoru Sugie.


Cancers | 2018

Dysregulated HAI-2 Plays an Important Role in Renal Cell Carcinoma Bone Metastasis through Ligand-Dependent MET Phosphorylation

Koji Yamasaki; Shoichiro Mukai; Satoru Sugie; Takahiro Nagai; Kozue Nakahara; Toyoharu Kamibeppu; Hiromasa Sakamoto; Noboru Shibasaki; Naoki Terada; Yoshinobu Toda; Hiroaki Kataoka; Toshiyuki Kamoto

MET, a c-met proto-oncogene product and hepatocyte growth factor (HGF) receptor, is known to play an important role in cancer progression, including bone metastasis. In a previous study, we reported increased expression of MET and matriptase, a novel activator of HGF, in bone metastasis. In this study, we employed a mouse model of renal cell carcinoma (RCC) bone metastasis to clarify the significance of the HGF/MET signaling axis and the regulator of HGF activator inhibitor type-2 (HAI-2). Luciferase-transfected 786-O cells were injected into the left cardiac ventricle of mice to prepare the mouse model of bone metastasis. The formation of bone metastasis was confirmed by whole-body bioluminescent imaging, and specimens were extracted. Expression of HGF/MET-related molecules was analyzed. Based on the results, we produced HAI-2 stable knockdown 786-O cells, and analyzed invasiveness and motility. Expression of HGF and matriptase was increased in bone metastasis compared with the control, while that of HAI-2 was decreased. Furthermore, we confirmed increased phosphorylation of MET in bone metastasis. The expression of matriptase was upregulated, and both invasiveness and motility were increased significantly by knockdown of HAI-2. The significance of ligand-dependent MET activation in RCC bone metastasis is considered, and HAI-2 may be an important regulator in this system.


Medical & Surgical Urology | 2014

Pure Verrucous Carcinoma of the Penis: Two Cases

Shoichiro Mukai; Kozue Nakahara; Takahiro Nagai; Toyoharu Kamibeppu; Satoru Sugie; Hiromasa Tsukino; Toshio Kamimura; Hironobu Wakeda; Toshiyuki Kamoto

Verrucous carcinoma is a rare subtype of penile verruciform squamous cell carcinoma. However, in past literature, the diagnosis of verrucous carcinoma has been confused with giant condylomas, and papillary and warty carcinomas due to the absence of critical criteria in pathological diagnosis. We experienced two cases of penile verruciform tumor occurring in a 48-year-old Japanese male and an 88-year-old Japanese male. We performed partial penectomy without lymph node dissection after biopsy. Although we initially detected small palpablelymph node swelling in the latter case, unnecessary lymph node dissection could be avoided by pathological diagnosis using preoperative biopsy. The resected specimens were diagnosed in accordance with the World Health Organization (WHO) classification and current pathological reviews. Histopathological findings and immunohistochemical appearance were compatible with a diagnosis of verrucous carcinoma.


Human Cell | 2015

Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis

Shoichiro Mukai; Kenji Yorita; Yukari Kawagoe; Yuichi Katayama; Kozue Nakahara; Toyoharu Kamibeppu; Satoru Sugie; Hiromasa Tukino; Toshiyuki Kamoto; Hiroaki Kataoka


Human Cell | 2015

Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis

Shoichiro Mukai; Kenji Yorita; Koji Yamasaki; Takahiro Nagai; Toyoharu Kamibeppu; Satoru Sugie; Kazutaka Kida; Chie Onizuka; Hiromasa Tsukino; Toshio Kamimura; Toshiyuki Kamoto; Hiroaki Kataoka


Anticancer Research | 2013

Increased Plasma Caveolin-1 Levels Are Associated with Progression of Prostate Cancer among Japanese Men

Satoru Sugie; Shoichiro Mukai; Hiromasa Tsukino; Yoshinobu Toda; Takenori Yamauchi; Ichiro Nishikata; Yoshiki Kuroda; Kazuhiro Morishita; Toshiyuki Kamoto


Cancer Genomics & Proteomics | 2015

Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression.

Satoru Sugie; Shoichiro Mukai; Koji Yamasaki; Toyoharu Kamibeppu; Hiromasa Tsukino; Toshiyuki Kamoto


Tumor Biology | 2014

Cyclooxygenase 2 genotypes influence prostate cancer susceptibility in Japanese Men

Satoru Sugie; Hiromasa Tsukino; Shoichiro Mukai; Takahiro Akioka; Norihiko Shibata; Masafumi Nagano; Toshiyuki Kamoto


Human Cell | 2016

Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression

Satoru Sugie; Shoichiro Mukai; Koji Yamasaki; Toyoharu Kamibeppu; Hiromasa Tsukino; Toshiyuki Kamoto


Anticancer Research | 2013

Functional Polymorphism in the CAV1 T29107A Gene and Its Association with Prostate Cancer Risk among Japanese Men

Satoru Sugie; Hiromasa Tsukino; Takenori Yamauchi; Shoichiro Mukai; Masato Fujii; Norihiko Shibata; Yoshiki Kuroda; Toshiyuki Kamoto


in Vivo | 2014

Effect of dutasteride on microvessel density in benign prostatic hyperplasia.

Satoru Sugie; Shoichiro Mukai; Hiromasa Tsukino; Hideyasu Iwamoto; Takahiko Kobayashi; Yoshinobu Toda; Toshiyuki Kamoto

Collaboration


Dive into the Satoru Sugie's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge